Haven Health is About to Disrupt the U.S. Healthcare System

Background: Healthcare costs are increasing in the U.S. Healthcare market is fragmented and opaque. The Amazon, JP Morgan Chase, and Berkshire Hathaway partnered to form an independent healthcare company ‘Haven’, designed to support cost-containment in health care and to forge a better patient exper...

Full description

Bibliographic Details
Main Authors: María Teresa Bedoya Reina, Nicholas Brereton, Mihail Zilbermint
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2021.1906832
id doaj-36b963ef5c2b4402b6c1627003563bed
record_format Article
spelling doaj-36b963ef5c2b4402b6c1627003563bed2021-05-13T09:30:29ZengTaylor & Francis GroupJournal of Community Hospital Internal Medicine Perspectives2000-96662021-05-0111335736010.1080/20009666.2021.19068321906832Haven Health is About to Disrupt the U.S. Healthcare SystemMaría Teresa Bedoya Reina0Nicholas Brereton1Mihail Zilbermint2Johns Hopkins University Carey Business SchoolJohns Hopkins University Carey Business SchoolJohns Hopkins University Carey Business SchoolBackground: Healthcare costs are increasing in the U.S. Healthcare market is fragmented and opaque. The Amazon, JP Morgan Chase, and Berkshire Hathaway partnered to form an independent healthcare company ‘Haven’, designed to support cost-containment in health care and to forge a better patient experience. Limited information is available in the public domain about Haven’s strategy to deliver cost-effective healthcare for their employees. Objective: To describe the impact of Haven Health of modern healthcare. Methods: We reviewed literature in Pubmed (MEDLINE database of references and abstracts on life sciences and biomedical topics from the USA National Library of Medicine at the National Institutes of Health) and the public domain. Results: Amazon’s expertise and abilities in e-commerce such as logistics, supply, and big data management will support Haven’s quest to resolve inefficiencies in health care. Haven may attempt to directly negotiate with providers, bypassing insurance companies, to establish themselves as an independent payor. Additionally, Haven to establish themselves as a provider by building new low-cost primary care clinics, focusing on chronic disease prevention. The new healthcare system may leverage machine learning, artificial intelligence and big data analysis to support its initiatives and other ‘big data’ analytics to drive it all. Conclusions: Heaven Health may use its expertise to disrupt everything from the pharmaceutical supply chain to primary care and telehealth. More research is needed to evaluate the impact of Haven Healthcare on disease outcomes and healthcare costs.http://dx.doi.org/10.1080/20009666.2021.1906832havenhealthamazonjpmorgan chaseberkshire hathaway
collection DOAJ
language English
format Article
sources DOAJ
author María Teresa Bedoya Reina
Nicholas Brereton
Mihail Zilbermint
spellingShingle María Teresa Bedoya Reina
Nicholas Brereton
Mihail Zilbermint
Haven Health is About to Disrupt the U.S. Healthcare System
Journal of Community Hospital Internal Medicine Perspectives
haven
health
amazon
jpmorgan chase
berkshire hathaway
author_facet María Teresa Bedoya Reina
Nicholas Brereton
Mihail Zilbermint
author_sort María Teresa Bedoya Reina
title Haven Health is About to Disrupt the U.S. Healthcare System
title_short Haven Health is About to Disrupt the U.S. Healthcare System
title_full Haven Health is About to Disrupt the U.S. Healthcare System
title_fullStr Haven Health is About to Disrupt the U.S. Healthcare System
title_full_unstemmed Haven Health is About to Disrupt the U.S. Healthcare System
title_sort haven health is about to disrupt the u.s. healthcare system
publisher Taylor & Francis Group
series Journal of Community Hospital Internal Medicine Perspectives
issn 2000-9666
publishDate 2021-05-01
description Background: Healthcare costs are increasing in the U.S. Healthcare market is fragmented and opaque. The Amazon, JP Morgan Chase, and Berkshire Hathaway partnered to form an independent healthcare company ‘Haven’, designed to support cost-containment in health care and to forge a better patient experience. Limited information is available in the public domain about Haven’s strategy to deliver cost-effective healthcare for their employees. Objective: To describe the impact of Haven Health of modern healthcare. Methods: We reviewed literature in Pubmed (MEDLINE database of references and abstracts on life sciences and biomedical topics from the USA National Library of Medicine at the National Institutes of Health) and the public domain. Results: Amazon’s expertise and abilities in e-commerce such as logistics, supply, and big data management will support Haven’s quest to resolve inefficiencies in health care. Haven may attempt to directly negotiate with providers, bypassing insurance companies, to establish themselves as an independent payor. Additionally, Haven to establish themselves as a provider by building new low-cost primary care clinics, focusing on chronic disease prevention. The new healthcare system may leverage machine learning, artificial intelligence and big data analysis to support its initiatives and other ‘big data’ analytics to drive it all. Conclusions: Heaven Health may use its expertise to disrupt everything from the pharmaceutical supply chain to primary care and telehealth. More research is needed to evaluate the impact of Haven Healthcare on disease outcomes and healthcare costs.
topic haven
health
amazon
jpmorgan chase
berkshire hathaway
url http://dx.doi.org/10.1080/20009666.2021.1906832
work_keys_str_mv AT mariateresabedoyareina havenhealthisabouttodisrupttheushealthcaresystem
AT nicholasbrereton havenhealthisabouttodisrupttheushealthcaresystem
AT mihailzilbermint havenhealthisabouttodisrupttheushealthcaresystem
_version_ 1721442298612416512